Real‐World Effectiveness and Safety of Lebrikizumab in Moderate‐to‐Severe Atopic Dermatitis: A Multicenter Study From Spain
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Ricardo Ruíz‐Villaverde (ORCID: https://orcid.org/0000-0002-0381-6174)
- M. Rodríguez‐Serna (ORCID: https://orcid.org/0000-0002-2690-3668)
- Manuel Galán‐Gutiérrez (ORCID: https://orcid.org/0000-0002-3496-3572)
- E. Serra‐Baldrich (ORCID: https://orcid.org/0000-0001-7603-0300)
- F.J. Ortiz de Frutos (ORCID: https://orcid.org/0000-0002-0635-0971)
- J.M. Carrascosa (ORCID: https://orcid.org/0000-0003-4266-0771)
- Violeta Zaragoza‐Ninet
- José Carlos Armario Hita (ORCID: https://orcid.org/0000-0001-6620-4725)
- J A Suárez-Pérez
- Ignasi Figueras‐Nar
Institutions
- Hospital de Sant Pau (ES)
- Bellvitge University Hospital (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Universitario 12 De Octubre (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Hospital Universitario Reina Sofía (ES)
- Hospital General Universitario De Valencia (ES)
- Hospital Universitario Puerto Real (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1111/ijd.70185
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.00